{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:41:36Z","timestamp":1794559296268,"version":"4.9.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T00:00:00Z","timestamp":1685750400000},"content-version":"am","delay-in-days":306,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jiac.2022.05.001","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T04:50:10Z","timestamp":1652244610000},"page":"1208-1211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["A case of severe COVID-19 with pulmonary thromboembolism related to heparin-induced thrombocytopenia during prophylactic anticoagulation therapy"],"prefix":"10.1016","volume":"28","author":[{"given":"Kosaku","family":"Sasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4261-5030","authenticated-orcid":false,"given":"Masayuki","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8371-9904","authenticated-orcid":false,"given":"Azusa","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Hiramine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6677-6341","authenticated-orcid":false,"given":"Hiroaki","family":"Ikezaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Toyoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5082-3967","authenticated-orcid":false,"given":"Eiichi","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Shimono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2022.05.001_bib1","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/jth.14830","article-title":"Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia","volume":"18","author":"Cui","year":"2020","journal-title":"J Thromb Haemostasis"},{"key":"10.1016\/j.jiac.2022.05.001_bib2","doi-asserted-by":"crossref","first-page":"n311","DOI":"10.1136\/bmj.n311","article-title":"Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study","volume":"372","author":"Rentsch","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jiac.2022.05.001_bib3","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/bloodadvances.2020003763","article-title":"American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19","volume":"5","author":"Cuker","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jiac.2022.05.001_bib4","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1182\/blood-2016-11-709873","article-title":"Heparin-induced thrombocytopenia","volume":"129","author":"Arepally","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jiac.2022.05.001_bib5","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1161\/CIRCULATIONAHA.120.049015","article-title":"Heparin-induced thrombocytopenia in severe COVID-19","volume":"142","author":"Daviet","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jiac.2022.05.001_bib6","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1182\/bloodadvances.2021005314","article-title":"Heparin-induced thrombocytopenia in patients with COVID-19: a systematic review and meta-analysis","volume":"5","author":"Uaprasert","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jiac.2022.05.001_bib7","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1538-7836.2006.01787.x","article-title":"Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings","volume":"4","author":"Lo","year":"2006","journal-title":"J Thromb Haemostasis"},{"key":"10.1016\/j.jiac.2022.05.001_bib8","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1182\/blood-2005-04-1546","article-title":"Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis","volume":"106","author":"Martel","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jiac.2022.05.001_bib9","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.06-2109","article-title":"The incidence of recognized heparin-induced thrombocytopenia in a large, tertiary care teaching hospital","volume":"131","author":"Smythe","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.jiac.2022.05.001_bib10","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMoa2105911","article-title":"Therapeutic anticoagulation with heparin in noncritically ill patients with covid-19","volume":"385","author":"Investigators","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2022.05.001_bib11","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa2103417","article-title":"Therapeutic anticoagulation with heparin in critically ill patients with covid-19","volume":"385","author":"Investigators","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2022.05.001_bib12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.thromres.2021.05.018","article-title":"Spontaneous HIT syndrome: knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia","volume":"204","author":"Warkentin","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.jiac.2022.05.001_bib13","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3109\/09537104.2011.650245","article-title":"Rapid-onset heparin-induced thrombocytopenia without previous heparin exposure","volume":"23","author":"Olah","year":"2012","journal-title":"Platelets"},{"key":"10.1016\/j.jiac.2022.05.001_bib14","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1182\/blood-2014-04-566836","article-title":"Me or not me? The danger of spontaneity","volume":"123","author":"Greinacher","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jiac.2022.05.001_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-243315","article-title":"Autoimmune heparin-induced thrombocytopenia: a rare manifestation of COVID-19","volume":"14","author":"Julian","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jiac.2022.05.001_bib16","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1182\/blood-2011-11-376293","article-title":"How I treat heparin-induced thrombocytopenia","volume":"119","author":"Cuker","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jiac.2022.05.001_bib17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3324\/haematol.2011.048074","article-title":"Rapid exclusion or confirmation of heparin-induced thrombocytopenia: a single-center experience with 1,291 patients","volume":"97","author":"Nellen","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.jiac.2022.05.001_bib18","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/ijlh.13582","article-title":"The complicated relationships of heparin-induced thrombocytopenia and platelet factor 4 antibodies with COVID-19","volume":"43","author":"Favaloro","year":"2021","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jiac.2022.05.001_bib19","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","volume":"2","author":"Cuker","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jiac.2022.05.001_bib20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4103\/aer.aer_151_21","article-title":"Heparin-induced thrombocytopenia in COVID-19: a systematic review","volume":"15","author":"Sulakshana","year":"2021","journal-title":"Anesth Essays Res"},{"key":"10.1016\/j.jiac.2022.05.001_bib21","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/jcph.1635","article-title":"Rivaroxaban as an alternative agent for heparin-induced thrombocytopenia","volume":"60","author":"Farasatinasab","year":"2020","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jiac.2022.05.001_bib22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/17474086.2021.1905512","article-title":"Heparin-induced thrombocytopenia: pathophysiology, diagnosis and treatment","volume":"14","author":"Hvas","year":"2021","journal-title":"Expet Rev Hematol"},{"key":"10.1016\/j.jiac.2022.05.001_bib23","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/S0140-6736(21)01203-4","article-title":"Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial","volume":"397","author":"Lopes","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2022.05.001_bib24","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1007\/s11239-020-02248-8","article-title":"Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019","volume":"50","author":"Ogawa","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jiac.2022.05.001_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3400\/avd.ra.20-00145","article-title":"The primary prevention of venous thromboembolism in patients with COVID-19 in Japan: current status and future perspective","volume":"14","author":"Yamashita","year":"2021","journal-title":"Ann Vasc Dis"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X22001507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X22001507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:05:16Z","timestamp":1761159916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X22001507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S1341321X22001507"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2022.05.001","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case of severe COVID-19 with pulmonary thromboembolism related to heparin-induced thrombocytopenia during prophylactic anticoagulation therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2022.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}